Autorisation d’accès précoce refusée à la spécialité ZURZUVAE (zuranolone) dans l'indication « traitement de la dépression sévère du post-partum (DPP) suivant l’accouchement chez les adultes. »
See also
HAS opinions and decisions
23/06/2025
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
D59DyfpX61rGpXRu
